BP

Betta Pharmaceuticals

Hangzhou, China

About

Betta Pharmaceuticals is a state-level hi-tech pharmaceutical enterprise, established by a team of returned PhD holders, which focuses on R&D of innovative medicines based on independent IPR, integrating R&D, manufacturing and marketing. Betta Pharmaceuticals has been dedicating to the R&D and manufacturing of National Class A new medicines with independent IPR. Betta Pharmaceuticals is a state-level hi-tech pharmaceutical enterprise, established by a team of returned PhD holders in 2003, which focuses on R&D of innovative medicines based on independent IPR, integrating R&D, manufacturing and marketing. Betta Pharmaceuticals has been dedicating to diseases severely influencing human health, e.g. malignant tumors, diabetes, and cardio-cerebrovascular disease. Its headquarters is located at Yuhang Economic and Technological Development Zone, Hangzhou City, with a pharmaceutical R&D center established in Beijing and Hangzhou respectively. At present, it boasts a team of nearly 1,000 e

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 330 investors are based in Hangzhou, Zhejiang, China.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Sectors
healthtech

Contact Information

be••••@bettapharma.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Betta

Search Investors